speb/financial-data huggingface dataset:
Financial ratios for MEDICAMEQ.NS — annual report dated 2025-03-31
Total revenue: 19002478.372691136
Gross profit: 9110264.203881225
Operating income: 794037.8770166003
Net income: 830979.6586392331
Capital expenditures: 255845.21861117604
Operating cash flow: -953799.3920972644
Depreciation & amortization: 826057.9845686228
Net tangible assets: 24680009.352349777
Owner earnings: 1401192.4245966799
Return on net tangible assets (%): 5.677438791015987
Capex to operating income (%): 32.220782662465766
Buffett classification: The Good
Stock price: 5.584782355000583
P/E ratio: 91.15189416329844
Shares outstanding: 13562815
Book value: 24906827.215337854
P/B ratio: 3.0411488882651634
Market cap (USD): 75745369.89613724
Debt to equity: 0.15852487409236196
Current ratio: 2.105239388038658
Quick ratio: 1.31025513742007
Effective tax rate (%): 33.64676113360324
Interest coverage ratio: 2.152086435791008
COGS to revenue (%): 52.05749468462084
SG&A to revenue (%): 8.16058351051264
Free cash flow (dilution-adjusted): -1209644.6107084404
Buyback yield (%): 0
Retained earnings: 11258791.208791208
Inventory turnover: 1.3617885524659867
Receivables turnover: 2.359185889053218
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1016212252047706
FCF margin (%): -6.365720233876685
Revenue growth (%): -11.625104346714519
Rule of 40 score: -17.9908245805912
Financial ratios for MEDICAMEQ.NS — quarterly report dated 2025-03-31
Total revenue: 3461877.4842179096
Gross profit: 1852735.5623100302
Operating income: -244002.80570493336
Net income: 282464.3441664718
Capital expenditures: 0
Depreciation & amortization: 55985.503857844276
Net tangible assets: 24680009.352349777
Owner earnings: 338449.8480243161
Return on net tangible assets (%): 1.37135218707724
Buffett classification: The Gruesome
Stock price: 5.584782355000583
P/E ratio: 67.0397622394212
Shares outstanding: 13562815
Book value: 24906827.215337854
P/B ratio: 3.0411488882651634
Market cap (USD): 75745369.89613724
Debt to equity: 0.15852487409236196
Current ratio: 2.105239388038658
Quick ratio: 1.31025513742007
Effective tax rate (%): 25.161627113199213
Interest coverage ratio: -3.2115710109247577
COGS to revenue (%): 46.48176976925596
Buyback yield (%): 0
Retained earnings: 11258791.208791208
Inventory turnover: 0.22151876325691128
Receivables turnover: 0.42979722698357176
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.9531085393903886
Revenue growth (%): -34.2091281835944
Rule of 40 score: -34.2091281835944
Financial ratios for MEDICAMEQ.NS — quarterly report dated 2025-06-30
Total revenue: 5036835.946641704
Gross profit: 2379124.736718933
Operating income: 329288.55604961386
Net income: 251930.72782588348
Capital expenditures: 0
Depreciation & amortization: 210776.97168265856
Owner earnings: 462707.6995085421
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.857243154692254
P/E ratio: 75.28951575657064
Shares outstanding: 13562815
Market cap (USD): 65877890.317107424
Effective tax rate (%): 24.895584025529118
Interest coverage ratio: 2.4398300676261484
COGS to revenue (%): 52.765490837453065
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 45.494344314718035
Rule of 40 score: 45.494344314718035
Financial ratios for MEDICAMEQ.NS — quarterly report dated 2025-09-30
Total revenue: 5317903.043968433
Gross profit: 2707632.468996618
Operating income: 371927.8466741826
Net income: 300653.88951521984
Capital expenditures: 0
Depreciation & amortization: 209323.56257046224
Net tangible assets: 30975400.22547914
Owner earnings: 509977.4520856821
Return on net tangible assets (%): 1.646395037266362
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.329763246899662
P/E ratio: 38.413674085268106
Shares outstanding: 13562815
Book value: 31049661.781285234
P/B ratio: 1.4544751962071163
Market cap (USD): 45160962.91149944
Debt to equity: 0.1403308878928
Current ratio: 2.6103920837797636
Quick ratio: 1.8068954961249637
Effective tax rate (%): 21.19348466211935
Interest coverage ratio: 3.3360299322479525
COGS to revenue (%): 49.084583780300115
Buyback yield (%): 0
Inventory turnover: 0.33668274481119936
Receivables turnover: 0.6080886315176111
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.171839478948804
Revenue growth (%): 5.580231325861014
Rule of 40 score: 5.580231325861014
Financial ratios for MEDICAMEQ.NS — quarterly report dated 2025-12-31
Total revenue: 5225409.379525454
Gross profit: 2584259.774980506
Operating income: 283825.331402473
Net income: 182098.69666926592
Capital expenditures: 0
Depreciation & amortization: 203564.66525565335
Owner earnings: 385663.3619249193
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.0620474546062155
P/E ratio: 54.16401218166751
Shares outstanding: 13562815
Market cap (USD): 55092798.148044996
Effective tax rate (%): 22.559098015064666
Interest coverage ratio: 2.621296296296296
COGS to revenue (%): 50.54435763241204
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -1.7392882810807382
Rule of 40 score: -1.7392882810807382
Financial ratios for MLAA.PA — annual report dated 2023-12-31
Total revenue: 1871262.2222222222
Gross profit: 715806.6666666666
Operating income: 25652.222222222223
Net income: 51331.11111111111
Capital expenditures: 0
Depreciation & amortization: 101198.88888888889
Net tangible assets: -707618.8888888889
Owner earnings: 152530
Return on net tangible assets (%): -21.55538841529574
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.666666666666667
P/E ratio: 90.91302653794537
Shares outstanding: 1000000
Book value: 207912.22222222225
P/B ratio: 22.4453695736983
Market cap (USD): 4666666.666666667
Debt to equity: 4.346748895099962
Current ratio: 1.6923465374852527
Quick ratio: 1.6923465374852527
Effective tax rate (%): -13.250036059425934
Interest coverage ratio: 0.9478200180638804
COGS to revenue (%): 61.747388571944306
Buyback yield (%): 0
Retained earnings: 51331.11111111111
Receivables turnover: 8.011035689992246
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.178179149031721
Rule of 40 score: 0
Financial ratios for MMP.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.543979955162864
Shares outstanding: 25402613
Market cap (USD): 64623738.28075959
Buyback yield (%): 0
Retained earnings: 18776961.6246868
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MMP.NS — annual report dated 2023-03-31
Total revenue: 65521985.383678444
Gross profit: 9888708.891595615
Operating income: 3530036.540803898
Net income: 2596918.392204629
Capital expenditures: 2966492.0828258223
Operating cash flow: 3999123.0207064557
Depreciation & amortization: 834579.7807551767
Net tangible assets: 31269732.034104753
Owner earnings: 465006.0901339832
Return on net tangible assets (%): 1.4870805084828294
Capex to operating income (%): 84.03573301681065
Buffett classification: The Gruesome
Stock price: 1.349086479902558
P/E ratio: 13.196533959391576
Shares outstanding: 25402613
Book value: 31319951.27892814
P/B ratio: 1.0942009917989177
Market cap (USD): 34270321.75249696
Debt to equity: 0.22386177318843511
Current ratio: 1.6967429744954514
Quick ratio: 0.6391395452464221
Effective tax rate (%): 22.057022530443334
Interest coverage ratio: 6.491712212167369
COGS to revenue (%): 84.90780028460661
SG&A to revenue (%): 1.147684062494481
Free cash flow (dilution-adjusted): 284470.1583434836
Buyback yield (%): 0
Retained earnings: 19933873.325213157
Inventory turnover: 5.301389912542872
Receivables turnover: 12.069425466848852
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.481022729327524
FCF margin (%): 0.4341598574550295
Rule of 40 score: 0.4341598574550295
Financial ratios for MMP.NS — annual report dated 2024-03-31
Total revenue: 69363101.09125794
Gross profit: 11709929.248111283
Operating income: 4612159.73138266
Net income: 3794183.9549106606
Capital expenditures: 5075356.757404964
Operating cash flow: 5126537.95419115
Depreciation & amortization: 954970.6199784146
Net tangible assets: 34638625.73450054
Owner earnings: -326202.1825158894
Return on net tangible assets (%): -0.9417295738467696
Capex to operating income (%): 110.04295282469423
Buffett classification: The Gruesome
Stock price: 3.019433781190019
P/E ratio: 20.21554798981874
Shares outstanding: 25402613
Book value: 34655486.26933685
P/B ratio: 2.213257295730465
Market cap (USD): 76701507.82269673
Debt to equity: 0.32258217439161835
Current ratio: 1.4846771527974185
Quick ratio: 0.5390887220709653
Effective tax rate (%): 20.843361437041853
Interest coverage ratio: 5.620458863071752
COGS to revenue (%): 83.11792716316843
SG&A to revenue (%): 1.1779525184948139
Free cash flow (dilution-adjusted): -106655.4742774913
Buyback yield (%): 0
Retained earnings: 23115073.7498501
Inventory turnover: 4.331275067657901
Receivables turnover: 10.136727437142602
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.10930895569615
FCF margin (%): -0.15376399353478942
Revenue growth (%): 5.862331071146578
Rule of 40 score: 5.7085670776117885
Financial ratios for MMP.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.8970742510782137
Shares outstanding: 25402613
Market cap (USD): 98995869.03240469
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MMP.NS — annual report dated 2025-03-31
Total revenue: 80881447.27612813
Gross profit: 18358183.306055646
Operating income: 6327004.909983633
Net income: 4544715.9223754965
Capital expenditures: 5923322.422258592
Operating cash flow: 6638695.347205985
Depreciation & amortization: 1134615.3846153845
Net tangible assets: 37803483.75029226
Owner earnings: -243991.1152677117
Return on net tangible assets (%): -0.6454196572976568
Capex to operating income (%): 93.61969062031145
Buffett classification: The Gruesome
Stock price: 2.995098611273194
P/E ratio: 16.741053174395567
Shares outstanding: 25402613
Book value: 37811772.2702829
P/B ratio: 2.012159873786343
Market cap (USD): 76083330.91901039
Debt to equity: 0.48309789176974294
Current ratio: 1.3866544810884758
Quick ratio: 0.6073796308278182
Effective tax rate (%): 23.940115472582598
Interest coverage ratio: 5.309800151088525
COGS to revenue (%): 77.3023555780585
SG&A to revenue (%): 1.0937040866221615
Free cash flow (dilution-adjusted): 715372.924947393
Buyback yield (%): 0
Retained earnings: 26614753.331774607
Inventory turnover: 3.9647987925253405
Receivables turnover: 7.729069195879974
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.396620220950767
FCF margin (%): 0.8844709745426784
Revenue growth (%): 16.605869696794564
Rule of 40 score: 17.490340671337243
Financial ratios for MMP.NS — quarterly report dated 2025-03-31
Total revenue: 26084264.671498712
Gross profit: 5128688.332943652
Operating income: 1855471.1246200607
Net income: 1269967.2667757773
Capital expenditures: 0
Depreciation & amortization: 298199.6726677577
Net tangible assets: 37803483.75029226
Owner earnings: 1568166.9394435352
Return on net tangible assets (%): 4.148207476860943
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.995098611273194
P/E ratio: 14.977419676369399
Shares outstanding: 25402613
Book value: 37811772.2702829
P/B ratio: 2.012159873786343
Market cap (USD): 76083330.91901039
Debt to equity: 0.48309789176974294
Current ratio: 1.3866544810884758
Quick ratio: 0.6073796308278182
Effective tax rate (%): 24.202483951995536
Interest coverage ratio: 5.458319004058051
COGS to revenue (%): 80.33799918252026
Buyback yield (%): 0
Retained earnings: 26614753.331774607
Inventory turnover: 1.328859667395886
Receivables turnover: 2.492624617378287
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.221983939026931
Rule of 40 score: 0
Financial ratios for MMP.NS — quarterly report dated 2025-06-30
Total revenue: 21448069.27217412
Gross profit: 4064427.802480693
Operating income: 1170372.1039082613
Net income: -633208.5186051955
Capital expenditures: 0
Depreciation & amortization: 322688.9772993213
Owner earnings: -310519.5413058741
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.2580154458226076
Shares outstanding: 25402613
Market cap (USD): 82762105.51825416
Interest coverage ratio: 3.848255165249509
COGS to revenue (%): 81.04991292734343
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -17.7739164117223
Rule of 40 score: -17.7739164117223
Financial ratios for MMP.NS — quarterly report dated 2025-09-30
Total revenue: 21159019.16572717
Gross profit: 4340935.738444194
Operating income: 1133337.091319053
Net income: 790124.0135287485
Capital expenditures: 0
Depreciation & amortization: 315298.7598647125
Net tangible assets: 36149639.233370915
Owner earnings: 1105422.773393461
Return on net tangible assets (%): 3.0579081751195156
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.152198421645998
P/E ratio: 56.11818907176421
Shares outstanding: 25402613
Book value: 36149639.233370915
P/B ratio: 2.215072634262007
Market cap (USD): 80074076.60428411
Debt to equity: 0.5398991352804156
Current ratio: 1.2285271875690775
Quick ratio: 0.4691116546205402
Effective tax rate (%): 20.979580791737607
Interest coverage ratio: 2.9730281252772603
COGS to revenue (%): 79.48422984806626
Buyback yield (%): 0
Inventory turnover: 1.0774640054199522
Receivables turnover: 2.45974485195437
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.646537323924195
Revenue growth (%): -1.3476742488050142
Rule of 40 score: -1.3476742488050142
Financial ratios for MMP.NS — quarterly report dated 2025-12-31
Total revenue: 22651988.41483792
Gross profit: 4879982.1766737215
Operating income: 1647410.0479001894
Net income: 1272028.5173220453
Capital expenditures: 0
Depreciation & amortization: 324228.58415951877
Owner earnings: 1596257.101481564
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.8088448256655902
P/E ratio: 26.437326279694403
Shares outstanding: 25402613
Market cap (USD): 71351998.08343546
Effective tax rate (%): 20.588337563893045
Interest coverage ratio: 4.106745161200744
COGS to revenue (%): 78.4567160846809
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 7.055947335824639
Rule of 40 score: 7.055947335824639
Financial ratios for MPH.V — annual report dated 2021-12-31
Capital expenditures: 296850.3937007874
Buffett classification: The Gruesome
Stock price: 0.7244094488188977
Shares outstanding: 10436313
Market cap (USD): 7560163.748031497
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MPH.V — annual report dated 2022-12-31
Total revenue: 16959558.82352941
Gross profit: 11819852.94117647
Operating income: 877205.8823529411
Net income: 1003676.4705882352
Capital expenditures: 10294.117647058823
Operating cash flow: 1344117.6470588234
Depreciation & amortization: 1511029.4117647058
Net tangible assets: 5297058.823529411
Owner earnings: 2504411.764705882
Return on net tangible assets (%): 47.27928928373126
Capex to operating income (%): 1.1735121542330262
Buffett classification: The Great
Stock price: 0.7426470588235293
P/E ratio: 7.722107054945055
Shares outstanding: 10436313
Book value: 15444852.94117647
P/B ratio: 0.5018174782194715
Market cap (USD): 7750497.154411764
Debt to equity: 0.04041894786955486
Current ratio: 1.769606674612634
Quick ratio: 1.3856972586412395
Effective tax rate (%): 1.4440433212996389
COGS to revenue (%): 30.30565792326035
R&D to revenue (%): 11.940169087361802
SG&A to revenue (%): 52.58183394753957
Free cash flow (dilution-adjusted): 1081617.6470588234
Buyback yield (%): 0
Retained earnings: -47742647.058823526
Inventory turnover: 2.1701334989133807
Receivables turnover: 4.093167701863354
Capitalized R&D asset: 2024999.9999999998
ROCI (R&D-adjusted, %): 12.484543730937265
FCF margin (%): 6.377628441361368
Rule of 40 score: 6.377628441361368
Financial ratios for MPH.V — annual report dated 2023-12-31
Total revenue: 16434848.484848484
Gross profit: 10597727.272727272
Operating income: -646969.6969696969
Net income: -698484.8484848485
Capital expenditures: 0
Operating cash flow: 1575000
Depreciation & amortization: 1643939.3939393938
Net tangible assets: 5950000
Owner earnings: 945454.5454545453
Buffett classification: The Gruesome
Stock price: 1.0606060606060606
Shares outstanding: 10436313
Book value: 15072727.27272727
P/B ratio: 0.7343605850422197
Market cap (USD): 11068816.818181818
Debt to equity: 0.027342179332529155
Current ratio: 1.9165616334761784
Quick ratio: 1.5510461305772623
Interest coverage ratio: -42.7
COGS to revenue (%): 35.51673273716235
R&D to revenue (%): 11.090624135705724
SG&A to revenue (%): 57.32921545127685
Free cash flow (dilution-adjusted): 1152272.7272727273
Buyback yield (%): 0
Retained earnings: -49887878.78787879
Inventory turnover: 2.656896551724138
Receivables turnover: 4.525239883187318
Capitalized R&D asset: 3179477.2727272725
ROCI (R&D-adjusted, %): -0.579724207514953
Rosenberg metric: -0.6035188486168884
FCF margin (%): 7.011155158108233
Revenue growth (%): -3.0938914398701947
Rule of 40 score: 3.917263718238038
Financial ratios for MPH.V — quarterly report dated 2024-09-30
Capital expenditures: 74074.07407407407
Buffett classification: The Gruesome
Stock price: 0.7481481481481481
Shares outstanding: 10436313
Market cap (USD): 7807908.244444444
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MPH.V — quarterly report dated 2024-12-31
Capital expenditures: 313286.7132867133
Buffett classification: The Gruesome
Stock price: 0.6153846153846154
Shares outstanding: 10436313
Market cap (USD): 6422346.461538462
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MPH.V — annual report dated 2024-12-31
Total revenue: 15319580.41958042
Gross profit: 9153146.853146853
Operating income: -1913986.013986014
Net income: -726573.4265734266
Capital expenditures: 0
Operating cash flow: 962937.0629370629
Depreciation & amortization: 1618181.8181818184
Net tangible assets: 5628671.328671329
Owner earnings: 891608.3916083918
Buffett classification: The Gruesome
Stock price: 0.6153846153846154
Shares outstanding: 10436313
Book value: 14530069.93006993
P/B ratio: 0.4420038232746174
Market cap (USD): 6422346.461538462
Debt to equity: 0.042063721243623065
Current ratio: 1.893627159023228
Quick ratio: 1.502680166765932
Interest coverage ratio: -273.7
COGS to revenue (%): 40.2519742548044
R&D to revenue (%): 14.063997808919524
SG&A to revenue (%): 58.177751403660935
Free cash flow (dilution-adjusted): 309090.9090909091
Buyback yield (%): 0
Retained earnings: -46776923.07692308
Inventory turnover: 2.6867763558805606
Receivables turnover: 4.134956587391469
Capitalized R&D asset: 4044022.7272727275
ROCI (R&D-adjusted, %): -9.299470759899304
Rosenberg metric: -0.792537886054095
FCF margin (%): 2.017619938832337
Revenue growth (%): -6.785995418797107
Rule of 40 score: -4.76837547996477
Financial ratios for MPH.V — quarterly report dated 2025-03-31
Total revenue: 3834965.034965035
Gross profit: 1988111.8881118882
Operating income: -458041.95804195805
Net income: -485314.68531468534
Capital expenditures: 0
Operating cash flow: 458741.25874125876
Depreciation & amortization: 452447.55244755244
Net tangible assets: 5032867.132867133
Owner earnings: -32867.132867132896
Return on net tangible assets (%): -0.6530498818952346
Buffett classification: The Gruesome
Stock price: 0.5524475524475525
Shares outstanding: 10436313
Book value: 14052447.552447554
P/B ratio: 0.41028550734013436
Market cap (USD): 5765515.5734265745
Debt to equity: 0.043592933565563576
Current ratio: 1.708748375920312
Quick ratio: 1.2852966652230404
COGS to revenue (%): 48.158278628738145
R&D to revenue (%): 10.393873085339168
SG&A to revenue (%): 53.39168490153173
Free cash flow (dilution-adjusted): 433566.4335664336
Buyback yield (%): 0
Retained earnings: -47262237.762237765
Inventory turnover: 0.6752748657632319
Receivables turnover: 1.2293207800941492
Capitalized R&D asset: 398601.3986013986
ROCI (R&D-adjusted, %): -1.3025767336112164
FCF margin (%): 11.305616338439096
Rule of 40 score: 11.305616338439096
Financial ratios for MPH.V — quarterly report dated 2025-06-30
Total revenue: 4867883.211678832
Gross profit: 2507299.2700729924
Operating income: -510218.9781021897
Net income: -573722.6277372262
Capital expenditures: 0
Operating cash flow: -532116.7883211678
Depreciation & amortization: 468613.13868613134
Net tangible assets: 3848905.1094890507
Owner earnings: -105109.48905109486
Return on net tangible assets (%): -2.730893229660534
Buffett classification: The Gruesome
Stock price: 0.9124087591240875
Shares outstanding: 10436313
Book value: 13362773.722627737
P/B ratio: 0.7125903342983558
Market cap (USD): 9522183.394160584
Debt to equity: 0.059649314469874905
Current ratio: 1.4836738993048242
Quick ratio: 1.0620391826416684
COGS to revenue (%): 48.49302744039586
R&D to revenue (%): 11.111111111111112
SG&A to revenue (%): 50.87719298245613
Free cash flow (dilution-adjusted): -554014.5985401459
Buyback yield (%): 0
Retained earnings: -49905839.41605839
Inventory turnover: 0.8078940794404198
Receivables turnover: 1.311504424778761
Capitalized R&D asset: 807938.8494716962
ROCI (R&D-adjusted, %): -1.9327359016004317
Rosenberg metric: 1.302522730183121
FCF margin (%): -11.381016644174538
Revenue growth (%): 26.93422670862016
Rule of 40 score: 15.55321006444562
Financial ratios for MPH.V — quarterly report dated 2025-09-30
Total revenue: 5869784.172661871
Gross profit: 1994964.0287769786
Operating income: -942446.0431654677
Net income: -1004316.54676259
Capital expenditures: 0
Operating cash flow: -373381.2949640288
Depreciation & amortization: 487769.7841726619
Net tangible assets: 3276978.4172661873
Owner earnings: -516546.76258992805
Return on net tangible assets (%): -15.762897914379801
Buffett classification: The Gruesome
Stock price: 0.7913669064748202
Shares outstanding: 10436313
Book value: 12451798.56115108
P/B ratio: 0.6632738791310377
Market cap (USD): 8258952.733812951
Debt to equity: 0.05777675063554426
Current ratio: 1.4390106801573919
Quick ratio: 1.0006745362563239
Interest coverage ratio: -655
COGS to revenue (%): 66.01299178820935
R&D to revenue (%): 8.787841647260693
SG&A to revenue (%): 41.255055766638066
Free cash flow (dilution-adjusted): -398561.1510791367
Buyback yield (%): 0
Retained earnings: -50192086.330935255
Inventory turnover: 1.3813798409848679
Receivables turnover: 1.8094921268573962
Capitalized R&D asset: 1009752.6609818265
ROCI (R&D-adjusted, %): -6.589644337688972
Rosenberg metric: -0.9472324974028865
FCF margin (%): -6.790047799975488
Revenue growth (%): 20.581861096817562
Rule of 40 score: 13.791813296842074
Financial ratios for MPH.V — annual report dated 2025-12-31
Total revenue: 21062043.795620438
Gross profit: 8575182.481751824
Operating income: -5027737.226277372
Net income: -5180291.970802919
Capital expenditures: 0
Operating cash flow: -408759.1240875912
Depreciation & amortization: 1931386.8613138685
Net tangible assets: 657664.2335766422
Owner earnings: -3248905.1094890507
Return on net tangible assets (%): -494.0066592674806
Buffett classification: The Gruesome
Stock price: 0.8321167883211678
Shares outstanding: 10436313
Book value: 9422627.737226276
P/B ratio: 0.9216358215198698
Market cap (USD): 8684231.255474452
Debt to equity: 0.06902161282825936
Current ratio: 1.0235942478257125
Quick ratio: 0.7702574700766384
Interest coverage ratio: -135.05882352941177
COGS to revenue (%): 59.28608560041587
R&D to revenue (%): 11.017154739213307
SG&A to revenue (%): 53.56783919597989
Free cash flow (dilution-adjusted): -508029.1970802919
Buyback yield (%): 0
Retained earnings: -54005839.41605839
Inventory turnover: 5.814751869476546
Receivables turnover: 5.9902428897654145
Capitalized R&D asset: 4365483.410749834
ROCI (R&D-adjusted, %): -34.089416731395126
Rosenberg metric: -0.268253505710773
FCF margin (%): -2.4120603015075375
Revenue growth (%): 37.4844690178355
Rule of 40 score: 35.07240871632796
Financial ratios for MPH.V — quarterly report dated 2025-12-31
Total revenue: 6235766.423357664
Gross profit: 1968613.1386861312
Operating income: -3083211.6788321165
Net income: -3081021.897810219
Capital expenditures: 0
Operating cash flow: 23357.66423357664
Depreciation & amortization: 495620.43795620435
Net tangible assets: 657664.2335766422
Owner earnings: -2585401.4598540147
Return on net tangible assets (%): -393.118756936737
Buffett classification: The Gruesome
Stock price: 0.8321167883211678
Shares outstanding: 10436313
Book value: 9422627.737226276
P/B ratio: 0.9216358215198698
Market cap (USD): 8684231.255474452
Debt to equity: 0.06902161282825936
Current ratio: 1.0235942478257125
Quick ratio: 0.7702574700766384
COGS to revenue (%): 68.43029380779586
R&D to revenue (%): 13.473018845838697
SG&A to revenue (%): 67.54067657731476
Free cash flow (dilution-adjusted): -2189.7810218978084
Buyback yield (%): 0
Retained earnings: -54005839.41605839
Inventory turnover: 1.9870836165873558
Receivables turnover: 1.77351048370355
Capitalized R&D asset: 1364239.353043113
ROCI (R&D-adjusted, %): -25.907436813659924
Rosenberg metric: -0.051084710217960766
FCF margin (%): -0.03511646962425375
Revenue growth (%): 6.23502057197147
Rule of 40 score: 6.199904102347216
Financial ratios for NAVA.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.8639061057628907
Shares outstanding: 283255096
Market cap (USD): 244705806.92285377
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NAVA.NS — annual report dated 2023-03-31
Total revenue: 427323142.50913525
Gross profit: 254740535.93179053
Operating income: 153772143.727162
Net income: 148805371.49817297
Capital expenditures: 10659439.70767357
Operating cash flow: 149018660.17052376
Depreciation & amortization: 37297137.637028016
Net tangible assets: 678223641.9001218
Owner earnings: 175443069.4275274
Return on net tangible assets (%): 25.868026206813344
Capex to operating income (%): 6.931970543758966
Buffett classification: The Great
Stock price: 1.2730816077953715
P/E ratio: 2.423345672278637
Shares outstanding: 283255096
Book value: 865728233.861145
P/B ratio: 0.4165358583993581
Market cap (USD): 360606853.0319123
Debt to equity: 0.43255674803951494
Current ratio: 2.15534503528211
Quick ratio: 1.7987682015605002
Effective tax rate (%): 3.482886704537131
Interest coverage ratio: 3.250813366845635
COGS to revenue (%): 40.38690850300842
SG&A to revenue (%): 4.307035013594814
Free cash flow (dilution-adjusted): 136782070.6455542
Buyback yield (%): 0
Inventory turnover: 2.058208126802417
Receivables turnover: 1.5010876535226765
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.67884379548529
FCF margin (%): 32.00904819767165
Rule of 40 score: 32.00904819767165
Financial ratios for NAVA.NS — annual report dated 2024-03-31
Total revenue: 455925050.96534353
Gross profit: 246543746.25254828
Operating income: 169867981.77239478
Net income: 150626897.7095575
Capital expenditures: 19830507.255066555
Operating cash flow: 381926993.64432186
Depreciation & amortization: 38219270.89579086
Net tangible assets: 772837438.5417916
Owner earnings: 169015661.3502818
Return on net tangible assets (%): 21.86949711820181
Capex to operating income (%): 11.674070091465117
Buffett classification: The Great
Stock price: 2.843809980806142
P/E ratio: 5.347807605200981
Shares outstanding: 283255096
Book value: 997790778.2707758
P/B ratio: 0.8073071897046563
Market cap (USD): 805523669.1190019
Debt to equity: 0.0497147956308272
Current ratio: 5.037258041106073
Quick ratio: 4.153588607938261
Effective tax rate (%): 8.926178426060567
Interest coverage ratio: 5.319234241270852
COGS to revenue (%): 45.924501026970574
SG&A to revenue (%): 3.0455299491656804
Free cash flow (dilution-adjusted): 362078114.88188034
Buyback yield (%): 0
Inventory turnover: 2.89681657733037
Receivables turnover: 2.150498143775417
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.711266592334436
FCF margin (%): 79.41614835930636
Revenue growth (%): 6.693273921057726
Rule of 40 score: 86.10942228036409
Financial ratios for NAVA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 826966686.5742953
Buffett classification: The Gruesome
Stock price: 6.759197324414716
Shares outstanding: 283255096
Book value: 1074304801.7200193
P/B ratio: 1.7821544536938618
Market cap (USD): 1914577087.0100336
Debt to equity: 0.07601406872107137
Current ratio: 5.216115271357182
Quick ratio: 4.380769900844966
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NAVA.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.67245599720247
Shares outstanding: 283255096
Market cap (USD): 1606752068.0433614
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NAVA.NS — annual report dated 2025-03-31
Total revenue: 463536146.8318915
Gross profit: 265832359.13023144
Operating income: 173340238.4849193
Net income: 167641197.10077155
Capital expenditures: 99574374.5616086
Operating cash flow: 252168202.01075518
Depreciation & amortization: 41198456.86228665
Net tangible assets: 834126081.365443
Owner earnings: 109265279.4014496
Return on net tangible assets (%): 13.099372126403857
Capex to operating income (%): 57.444466115853196
Buffett classification: The Good
Stock price: 5.960905589917144
P/E ratio: 10.071849368290787
Shares outstanding: 283255096
Book value: 1100256441.4309096
P/B ratio: 1.5346030448347467
Market cap (USD): 1688456885.1189172
Debt to equity: 0.0949016965628435
Current ratio: 5.9784080944631555
Quick ratio: 4.7627422289448775
Effective tax rate (%): 10.740688517757555
Interest coverage ratio: 69.2383167096268
COGS to revenue (%): 42.65121265146132
SG&A to revenue (%): 3.16009111726695
Free cash flow (dilution-adjusted): 152577004.90998363
Buyback yield (%): 2.5147205307501963
Inventory turnover: 2.0682434477609477
Receivables turnover: 2.8136119019167616
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.989345773017162
FCF margin (%): 32.91588066061179
Revenue growth (%): 1.66937435230478
Rule of 40 score: 34.58525501291657
Financial ratios for NAVA.NS — quarterly report dated 2025-03-31
Total revenue: 119032499.41547813
Gross profit: 57172363.80640636
Operating income: 34077273.79003975
Net income: 35403133.03717559
Capital expenditures: 0
Depreciation & amortization: 10538286.181903202
Net tangible assets: 834126081.365443
Owner earnings: 45941419.219078794
Return on net tangible assets (%): 5.507730814971505
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.960905589917144
P/E ratio: 11.923075306258403
Shares outstanding: 283255096
Book value: 1100256441.4309096
P/B ratio: 1.5346030448347467
Market cap (USD): 1688456885.1189172
Debt to equity: 0.0949016965628435
Current ratio: 5.9784080944631555
Quick ratio: 4.7627422289448775
Effective tax rate (%): 6.518145480211617
Interest coverage ratio: 61.459655485040805
COGS to revenue (%): 51.96911424429682
Buyback yield (%): 0
Inventory turnover: 0.6471389427507266
Receivables turnover: 0.7225137874560406
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7501910128738856
Rule of 40 score: 0
Financial ratios for NAVA.NS — quarterly report dated 2025-06-30
Total revenue: 139623636.78914112
Gross profit: 79207910.13339575
Operating income: 58258401.591387786
Net income: 46699122.396442786
Capital expenditures: 0
Depreciation & amortization: 10584928.621577347
Owner earnings: 57284051.01802013
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.990872923004916
P/E ratio: 24.118708681889956
Shares outstanding: 283255096
Market cap (USD): 1980200380.929558
Effective tax rate (%): 25.471535984818445
Interest coverage ratio: 380.3485867074103
COGS to revenue (%): 43.270414698468926
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 17.298752420370896
Rule of 40 score: 17.298752420370896
Financial ratios for NAVA.NS — quarterly report dated 2025-09-30
Total revenue: 108650879.3686584
Gross profit: 57203799.32356257
Operating income: 24914351.74746336
Net income: 20011240.135287486
Capital expenditures: 0
Depreciation & amortization: 10627452.085682074
Net tangible assets: 857769684.3291996
Owner earnings: 30638692.220969558
Return on net tangible assets (%): 3.571901966310443
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.298196166854566
P/E ratio: 20.244642927479134
Shares outstanding: 283255096
Book value: 1125371702.3675308
P/B ratio: 1.836949739823906
Market cap (USD): 2067251255.869222
Debt to equity: 0.159866848953927
Current ratio: 7.757127988455711
Quick ratio: 6.57533448100117
Effective tax rate (%): 27.148336401936824
Interest coverage ratio: 79.25060068136992
COGS to revenue (%): 47.35081790781744
Buyback yield (%): 0
Inventory turnover: 0.6637419500476787
Receivables turnover: 1.0210212720423906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8548085003679189
Revenue growth (%): -22.183032996954246
Rule of 40 score: -22.183032996954246
Financial ratios for NAVA.NS — quarterly report dated 2025-12-31
Total revenue: 110406048.79135568
Gross profit: 66570079.09101036
Operating income: 36418246.63027738
Net income: 36282165.534142815
Capital expenditures: 0
Depreciation & amortization: 12886420.853291746
Owner earnings: 49168586.38743456
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.320597081430322
P/E ratio: 12.936397852421017
Shares outstanding: 283255096
Market cap (USD): 1790341333.0778658
Effective tax rate (%): 17.767623316440794
Interest coverage ratio: 432.09965635738837
COGS to revenue (%): 39.70431890302146
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 1.6154212767500065
Rule of 40 score: 1.6154212767500065
Financial ratios for NESN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 119.84615384615384
Shares outstanding: 2572220000
Market cap (USD): 308270673846.1538
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NESN.SW — annual report dated 2022-12-31
Total revenue: 103021739130.43478
Gross profit: 46777173913.04348
Operating income: 17030434782.608694
Net income: 10430434782.608696
Capital expenditures: 5827173913.043478
Operating cash flow: 12942391304.347826
Depreciation & amortization: 3848913043.4782605
Net tangible assets: -10344565217.391304
Owner earnings: 8452173913.043478
Return on net tangible assets (%): -81.7064200903646
Capex to operating income (%): 34.21623691600715
Buffett classification: The Good
Stock price: 101.95652173913042
P/E ratio: 25.14320925385577
Shares outstanding: 2572220000
Book value: 46513043478.26088
P/B ratio: 5.6383023929706475
Market cap (USD): 262254604347.82605
Debt to equity: 1.2692091979809306
Current ratio: 0.8770762457474485
Quick ratio: 0.5013758254952971
Effective tax rate (%): 24.189261031366293
Interest coverage ratio: 12.54443554843875
COGS to revenue (%): 54.59485123443765
R&D to revenue (%): 1.7894070479004007
SG&A to revenue (%): 26.625870436801012
Free cash flow (dilution-adjusted): 6976086956.521739
Buyback yield (%): 0
Retained earnings: 81121739130.43478
Inventory turnover: 3.445302616685532
Receivables turnover: 10.732646359415696
Capitalized R&D asset: 1843478260.8695652
ROCI (R&D-adjusted, %): 17.335727504764264
FCF margin (%): 6.7714707744249845
Rule of 40 score: 6.7714707744249845
Financial ratios for NESN.SW — annual report dated 2023-12-31
Total revenue: 111132142857.14287
Gross profit: 51217857142.85715
Operating income: 18655952380.95238
Net income: 13701190476.190477
Capital expenditures: 7384523809.523809
Operating cash flow: 18977380952.380955
Depreciation & amortization: 4116666666.666667
Net tangible assets: -13304761904.761906
Owner earnings: 10433333333.333334
Return on net tangible assets (%): -78.41803865425912
Capex to operating income (%): 39.582668623572204
Buffett classification: The Good
Stock price: 104.27380952380953
P/E ratio: 19.576049161525763
Shares outstanding: 2572220000
Book value: 43317857142.85713
P/B ratio: 6.191792392887571
Market cap (USD): 268215178333.33334
Debt to equity: 1.5181520872839205
Current ratio: 0.8320839175924928
Quick ratio: 0.5112986732822781
Effective tax rate (%): 18.21616940880107
Interest coverage ratio: 9.538040170419963
COGS to revenue (%): 53.912652247967344
R&D to revenue (%): 1.7739499309059357
SG&A to revenue (%): 27.117009994536744
Free cash flow (dilution-adjusted): 11423809523.809525
Buyback yield (%): 2.3231169912422547
Retained earnings: 81263095238.09525
Inventory turnover: 4.230665770006725
Receivables turnover: 10.371180979891124
Capitalized R&D asset: 3206559006.21118
ROCI (R&D-adjusted, %): 17.642049272680683
Rosenberg metric: 2.4088611859838287
FCF margin (%): 10.27948281218198
Revenue growth (%): 7.87251680583608
Rule of 40 score: 18.15199961801806
Financial ratios for NESN.SW — annual report dated 2024-12-31
Total revenue: 101911111111.11111
Gross profit: 47833333333.333336
Operating income: 17347777777.77778
Net income: 12415555555.555555
Capital expenditures: 6625555555.555555
Operating cash flow: 18527777777.77778
Depreciation & amortization: 3980000000
Net tangible assets: -15470000000
Owner earnings: 9770000000
Return on net tangible assets (%): -63.15449256625727
Capex to operating income (%): 38.19253186447191
Buffett classification: The Good
Stock price: 77.16666666666667
P/E ratio: 15.987173706819403
Shares outstanding: 2572220000
Book value: 40770000000
P/B ratio: 4.868522034175456
Market cap (USD): 198489643333.33334
Debt to equity: 1.7322105033657644
Current ratio: 0.8209411380444672
Quick ratio: 0.5115834169330192
Effective tax rate (%): 25.032102122516807
Interest coverage ratio: 8.48071700162955
COGS to revenue (%): 53.063672045355425
R&D to revenue (%): 1.8174880069777581
SG&A to revenue (%): 27.99716528565198
Free cash flow (dilution-adjusted): 11773333333.333332
Buyback yield (%): 2.618664475631555
Retained earnings: 73736666666.66667
Inventory turnover: 3.6704374057315237
Receivables turnover: 9.737764093852851
Capitalized R&D asset: 3781427191.1663213
ROCI (R&D-adjusted, %): 15.61041328642264
Rosenberg metric: -1.7167874396135274
FCF margin (%): 11.552551242913212
Revenue growth (%): -8.297358000092846
Rule of 40 score: 3.2551932428203667
Financial ratios for NESN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -15470000000
Buffett classification: The Gruesome
Stock price: 77.16666666666667
Shares outstanding: 2572220000
Book value: 40770000000
P/B ratio: 4.868522034175456
Market cap (USD): 198489643333.33334
Debt to equity: 1.7322105033657644
Current ratio: 0.8209411380444672
Quick ratio: 0.5115834169330192
Buyback yield (%): 0
Retained earnings: 73736666666.66667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NESN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -20386250000
Buffett classification: The Gruesome
Stock price: 94.67499999999998
Shares outstanding: 2572220000
Book value: 36308750000
P/B ratio: 6.707059000929527
Market cap (USD): 243524928499.99997
Debt to equity: 2.2585464936137982
Current ratio: 0.7139928241927217
Quick ratio: 0.40573210319494274
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OLP — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.97
Shares outstanding: 21819448
Market cap (USD): 544831616.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OLP — annual report dated 2022-12-31
Total revenue: 92216000
Gross profit: 76708000
Operating income: 37384000
Net income: 42253000
Capital expenditures: 0
Operating cash flow: 44197000
Depreciation & amortization: 23781000
Net tangible assets: 296124000
Owner earnings: 66034000
Return on net tangible assets (%): 22.299442125596034
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.89
P/E ratio: 8.721995520318083
Shares outstanding: 21819448
Book value: 316937000
P/B ratio: 1.162787799215617
Market cap (USD): 368530476.72
Debt to equity: 1.3448414038121141
Current ratio: 0.45565749235474007
Quick ratio: 0.45565749235474007
Interest coverage ratio: 2.1278388069895837
COGS to revenue (%): 17.718183395506205
SG&A to revenue (%): 16.545935629391863
Free cash flow (dilution-adjusted): 44197000
Buyback yield (%): 1.4218634091370461
Retained earnings: -32102000
Receivables turnover: 5.735182536227377
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.098578333496994
FCF margin (%): 47.92769150689685
Rule of 40 score: 47.92769150689685
Financial ratios for OLP — annual report dated 2023-12-31
Total revenue: 90646000
Gross profit: 74202000
Operating income: 33307000
Net income: 29918000
Capital expenditures: 0
Operating cash flow: 46053000
Depreciation & amortization: 24789000
Net tangible assets: 292022000
Owner earnings: 54707000
Return on net tangible assets (%): 18.73386251720761
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 18.17
P/E ratio: 13.251533196069259
Shares outstanding: 21819448
Book value: 307745000
P/B ratio: 1.2882723363823947
Market cap (USD): 396459370.16
Debt to equity: 1.3593949536141936
Current ratio: 1.695294673066331
Quick ratio: 1.695294673066331
Interest coverage ratio: 1.7735356762513312
COGS to revenue (%): 19.191139156719547
SG&A to revenue (%): 17.45471394214858
Free cash flow (dilution-adjusted): 46053000
Buyback yield (%): 2.431018340192179
Retained earnings: -40843000
Receivables turnover: 5.440609807334494
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.524251957380452
FCF margin (%): 50.805330626834056
Revenue growth (%): -1.7025245076776263
Rule of 40 score: 49.10280611915643
Financial ratios for OLP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.13
Shares outstanding: 21819448
Market cap (USD): 526503280.23999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OLP — annual report dated 2024-12-31
Total revenue: 90563000
Gross profit: 72659000
Operating income: 32979000
Net income: 30798000
Capital expenditures: 0
Operating cash flow: 39059000
Depreciation & amortization: 24291000
Net tangible assets: 293776000
Owner earnings: 55089000
Return on net tangible assets (%): 18.7520423724198
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 24.26
P/E ratio: 17.187473487888827
Shares outstanding: 21819448
Book value: 308575000
P/B ratio: 1.7154332284857816
Market cap (USD): 529339808.48
Debt to equity: 1.362893947986713
Current ratio: 2.2745857625038357
Quick ratio: 2.2745857625038357
Interest coverage ratio: 1.6944458716539075
COGS to revenue (%): 21.10574958868412
SG&A to revenue (%): 16.99148658944602
Free cash flow (dilution-adjusted): 39059000
Buyback yield (%): 0
Retained earnings: -49020000
Receivables turnover: 5.330998351777725
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.451316134013243
FCF margin (%): 43.12909245497609
Revenue growth (%): -0.09156498907839286
Rule of 40 score: 43.037527465897696
Financial ratios for OLP — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.26
Shares outstanding: 21819448
Market cap (USD): 529339808.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OLP — quarterly report dated 2025-03-31
Total revenue: 24170000
Gross profit: 19132000
Operating income: 8511000
Net income: 4169000
Capital expenditures: 0
Operating cash flow: 10996000
Depreciation & amortization: 6545000
Net tangible assets: 282978000
Owner earnings: 10714000
Return on net tangible assets (%): 3.786160054845253
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 23.8
P/E ratio: 31.14073293355721
Shares outstanding: 21819448
Book value: 304332000
P/B ratio: 1.7063695648173705
Market cap (USD): 519302862.40000004
Debt to equity: 1.5475566158011644
Current ratio: 0.8847665078757954
Quick ratio: 0.8847665078757954
Interest coverage ratio: 1.5668262150220913
COGS to revenue (%): 21.886636326023996
SG&A to revenue (%): 17.25279271824576
Free cash flow (dilution-adjusted): 10996000
Buyback yield (%): 0
Retained earnings: -54669000
Receivables turnover: 1.3984840594804142
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0870717523555775
FCF margin (%): 45.494414563508485
Rule of 40 score: 45.494414563508485
Financial ratios for OLP — quarterly report dated 2025-06-30
Total revenue: 24545000
Gross profit: 19654000
Operating income: 8822000
Net income: 9418000
Capital expenditures: 0
Operating cash flow: 11228000
Depreciation & amortization: 6827000
Net tangible assets: 284427000
Owner earnings: 16245000
Return on net tangible assets (%): 5.711483087048698
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 22.01
P/E ratio: 35.345996208140136
Shares outstanding: 21819448
Book value: 303764000
P/B ratio: 1.5809840879103516
Market cap (USD): 480246050.48
Debt to equity: 1.4980511186315693
Current ratio: 1.1488900920411478
Quick ratio: 1.1488900920411478
Interest coverage ratio: 1.508807935693518
COGS to revenue (%): 21.05113057649216
SG&A to revenue (%): 16.044000814829904
Free cash flow (dilution-adjusted): 11228000
Buyback yield (%): 0
Retained earnings: -55939000
Receivables turnover: 1.4411954670894251
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1544309893141198
FCF margin (%): 45.74455082501528
Revenue growth (%): 1.551510136532892
Rule of 40 score: 47.29606096154817
Financial ratios for OLP — quarterly report dated 2025-09-30
Total revenue: 23771000
Gross profit: 18947000
Operating income: 8092000
Net income: 11105000
Capital expenditures: 0
Operating cash flow: 10873000
Depreciation & amortization: 6698000
Net tangible assets: 286056000
Owner earnings: 17803000
Return on net tangible assets (%): 6.223606566546411
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 20.81
P/E ratio: 18.389061756034344
Shares outstanding: 21819448
Book value: 305772000
P/B ratio: 1.4849715241421713
Market cap (USD): 454062712.88
Debt to equity: 1.500042515338226
Current ratio: 2.0327453015104346
Quick ratio: 1.3705753487835812
Interest coverage ratio: 1.440626669040413
COGS to revenue (%): 21.273821042446677
SG&A to revenue (%): 17.365697698876783
Free cash flow (dilution-adjusted): 10873000
Buyback yield (%): 0
Retained earnings: -55302000
Inventory turnover: 0.29351674502292646
Receivables turnover: 1.4098214815254138
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.042399321899403
FCF margin (%): 45.740608304236254
Revenue growth (%): -3.153391729476472
Rule of 40 score: 42.58721657475978
Financial ratios for OLP — annual report dated 2025-12-31
Total revenue: 97227000
Gross profit: 77349000
Operating income: 33813000
Net income: 27107000
Capital expenditures: 0
Operating cash flow: 37520000
Depreciation & amortization: 27196000
Net tangible assets: 274102000
Owner earnings: 54303000
Return on net tangible assets (%): 19.811238152220707
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 19.51
P/E ratio: 15.704335798133323
Shares outstanding: 21819448
Book value: 299797000
P/B ratio: 1.419952269302228
Market cap (USD): 425697430.48
Debt to equity: 1.7256410170882297
Current ratio: 1.1534655266509004
Quick ratio: 1.1534655266509004
Interest coverage ratio: 1.4831564172295815
COGS to revenue (%): 21.47448753946949
SG&A to revenue (%): 16.73094922192395
Free cash flow (dilution-adjusted): 37520000
Buyback yield (%): 0
Retained earnings: -62718000
Receivables turnover: 5.630146505298511
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.073438262346627
FCF margin (%): 38.59010357205303
Revenue growth (%): 7.358413480118813
Rule of 40 score: 45.948517052171844